Advertisement
Advertisement
December 10, 2012
Sequent Medical's Via Microcatheter Receives CE Mark Approval for Cerebral Aneurysm Treatment
December 11, 2012—Sequent Medical, Inc. (Aliso Viejo, CA) announced it has received CE Mark approval for the Via microcatheter. The company is initiating commercial introduction of this new product family in select markets. The device is currently available in two CE Mark–approved models, the Via and the Via Plus. They are not available for sale or use in the United States.
According to Sequent Medical, the Via is designed for delivery and deployment of the company's Web aneurysm embolization system for the treatment of cerebral aneurysms. The Web system builds on the foundation of endovascular embolic coils. It is a low-porosity, intrasaccular neurovascular embolization device designed to bridge the neck of a ruptured or unruptured intracranial aneurysm and to promote rapid periprocedural stasis.
"The Via microcatheter provides an optimal combination of properties for stable Web placement, retrieval, and navigability and will enable physicians to treat a broader range of aneurysm with the Web," commented Werner Weber, MD. Dr. Weber serves as Head of the Department of Radiology and Interventional Neuroradiology at Klinikum Vest, Knappschaftskrankenhaus in Recklinghausen, Germany.
Advertisement
Advertisement
